Article
Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications.
The Journal of biological chemistry - 13 Nov 2009
Zhao Ming, Wan Zhu-li, Whittaker Linda, Xu Bin, Phillips Nelson B, Katsoyannis Panayotis G, Ismail-Beigi Faramarz, Whittaker Jonathan, Weiss Michael A
Abstract excerpt
Insulin binds with high affinity to the insulin receptor (IR) and with low affinity to the type 1 insulin-like growth factor (IGF) receptor (IGFR). Such cross-binding, which reflects homologies within the insulin-IGF signaling system, is of clinical interest in relation to the association between hyperinsulinemia and colorectal cancer. Here, we employ nonstandard mutagenesis to design an insulin analog with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
